Global Microbiome Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • ID:PD025120
  • March 2021
  • GIR (Global Info Research)
                          

The Global Microbiome Therapeutics Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.

The Microbiome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microbiome Therapeutics size is estimated to be USD 191.6 million in 2026 from USD 62 million in 2020, with a change XX% between 2020 and 2021. The global Microbiome Therapeutics market size is expected to grow at a CAGR of 32.7% for the next five years.

Market segmentation
Microbiome Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

  •     Upper GIT
  •     Lower GIT

Market segment by Application, can be divided into
  •     Inflammatory Bowel Disease (IBD)
  •     Orphan Drug
  •     Immuno-Oncology
  •     Others

Market segment by players, this report covers
  •     Seres Therapeutics
  •     Assembly Biosciences
  •     Synthetic Biologics
  •     Interxon
  •     PureTech
  •     Synlogic
  •     Enterome BioScience
  •     4D Pharma
  •     Second Genome
  •     AOBiome
  •     C3 Jian
  •     Rebiotix
  •     MicroBiome Therapeutics LLC
  •     Metabiomics
  •     Ritter Pharmaceuticals
  •     Symberix
  •     OpenBiome
  •     Azitra
  •     Symbiotix Biotherapies
  •     Osel
  •     Metabogen

Market segment by regions, regional analysis covers
  •     North America (United States, Canada, and Mexico)
  •     Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  •     Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  •     South America (Brazil, Argentina, Rest of South America)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

There are 12 Chapters to deeply display the Global Microbiome Therapeutics Market.
1 Market Overview
2 Company Profiles
3 Market Competition, by Players
4 Market Size Segment by Type
5 Market Size Segment by Application
6 North America by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
9 South America by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
11 Research Findings and Conclusion
12 Appendix

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Microbiome Therapeutics
    1.2 Classification of Microbiome Therapeutics by Type
        1.2.1 Overview: Global Microbiome Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Microbiome Therapeutics Revenue Market Share by Type in 2020
        1.2.3 Upper GIT
        1.2.4 Lower GIT
    1.3 Global Microbiome Therapeutics Market by Application
        1.3.1 Overview: Global Microbiome Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Inflammatory Bowel Disease (IBD)
        1.3.3 Orphan Drug
        1.3.4 Immuno-Oncology
        1.3.5 Others
    1.4 Global Microbiome Therapeutics Market Size & Forecast
    1.5 Global Microbiome Therapeutics Market Size and Forecast by Region
        1.5.1 Global Microbiome Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Microbiome Therapeutics Market Size by Region, (2016-2021)
        1.5.3 North America Microbiome Therapeutics Market Size and Prospect (2016-2026)
        1.5.4 Europe Microbiome Therapeutics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Microbiome Therapeutics Market Size and Prospect (2016-2026)
        1.5.6 South America Microbiome Therapeutics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Microbiome Therapeutics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Microbiome Therapeutics Market Drivers
        1.6.2 Microbiome Therapeutics Market Restraints
        1.6.3 Microbiome Therapeutics Trends Analysis
2 Company Profiles
    2.1 Seres Therapeutics
        2.1.1 Seres Therapeutics Details
        2.1.2 Seres Therapeutics Major Business
        2.1.3 Seres Therapeutics Microbiome Therapeutics Product and Solutions
        2.1.4 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Seres Therapeutics Recent Developments and Future Plans
    2.2 Assembly Biosciences
        2.2.1 Assembly Biosciences Details
        2.2.2 Assembly Biosciences Major Business
        2.2.3 Assembly Biosciences Microbiome Therapeutics Product and Solutions
        2.2.4 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Assembly Biosciences Recent Developments and Future Plans
    2.3 Synthetic Biologics
        2.3.1 Synthetic Biologics Details
        2.3.2 Synthetic Biologics Major Business
        2.3.3 Synthetic Biologics Microbiome Therapeutics Product and Solutions
        2.3.4 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Synthetic Biologics Recent Developments and Future Plans
    2.4 Interxon
        2.4.1 Interxon Details
        2.4.2 Interxon Major Business
        2.4.3 Interxon Microbiome Therapeutics Product and Solutions
        2.4.4 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Interxon Recent Developments and Future Plans
    2.5 PureTech
        2.5.1 PureTech Details
        2.5.2 PureTech Major Business
        2.5.3 PureTech Microbiome Therapeutics Product and Solutions
        2.5.4 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 PureTech Recent Developments and Future Plans
    2.6 Synlogic
        2.6.1 Synlogic Details
        2.6.2 Synlogic Major Business
        2.6.3 Synlogic Microbiome Therapeutics Product and Solutions
        2.6.4 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Synlogic Recent Developments and Future Plans
    2.7 Enterome BioScience
        2.7.1 Enterome BioScience Details
        2.7.2 Enterome BioScience Major Business
        2.7.3 Enterome BioScience Microbiome Therapeutics Product and Solutions
        2.7.4 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Enterome BioScience Recent Developments and Future Plans
    2.8 4D Pharma
        2.8.1 4D Pharma Details
        2.8.2 4D Pharma Major Business
        2.8.3 4D Pharma Microbiome Therapeutics Product and Solutions
        2.8.4 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 4D Pharma Recent Developments and Future Plans
    2.9 Second Genome
        2.9.1 Second Genome Details
        2.9.2 Second Genome Major Business
        2.9.3 Second Genome Microbiome Therapeutics Product and Solutions
        2.9.4 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Second Genome Recent Developments and Future Plans
    2.10 AOBiome 
        2.10.1 AOBiome Details
        2.10.2 AOBiome Major Business
        2.10.3 AOBiome Microbiome Therapeutics Product and Solutions
        2.10.4 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 AOBiome Recent Developments and Future Plans
    2.11 C3 Jian
        2.11.1 C3 Jian Details
        2.11.2 C3 Jian Major Business
        2.11.3 C3 Jian Microbiome Therapeutics Product and Solutions
        2.11.4 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 C3 Jian Recent Developments and Future Plans
    2.12 Rebiotix
        2.12.1 Rebiotix Details
        2.12.2 Rebiotix Major Business
        2.12.3 Rebiotix Microbiome Therapeutics Product and Solutions
        2.12.4 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Rebiotix Recent Developments and Future Plans
    2.13 MicroBiome Therapeutics LLC
        2.13.1 MicroBiome Therapeutics LLC Details
        2.13.2 MicroBiome Therapeutics LLC Major Business
        2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions
        2.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
    2.14 Metabiomics
        2.14.1 Metabiomics Details
        2.14.2 Metabiomics Major Business
        2.14.3 Metabiomics Microbiome Therapeutics Product and Solutions
        2.14.4 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Metabiomics Recent Developments and Future Plans
    2.15 Ritter Pharmaceuticals
        2.15.1 Ritter Pharmaceuticals Details
        2.15.2 Ritter Pharmaceuticals Major Business
        2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions
        2.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Ritter Pharmaceuticals Recent Developments and Future Plans
    2.16 Symberix
        2.16.1 Symberix Details
        2.16.2 Symberix Major Business
        2.16.3 Symberix Microbiome Therapeutics Product and Solutions
        2.16.4 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Symberix Recent Developments and Future Plans
    2.17 OpenBiome
        2.17.1 OpenBiome Details
        2.17.2 OpenBiome Major Business
        2.17.3 OpenBiome Microbiome Therapeutics Product and Solutions
        2.17.4 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 OpenBiome Recent Developments and Future Plans
    2.18 Azitra
        2.18.1 Azitra Details
        2.18.2 Azitra Major Business
        2.18.3 Azitra Microbiome Therapeutics Product and Solutions
        2.18.4 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 Azitra Recent Developments and Future Plans
    2.19 Symbiotix Biotherapies
        2.19.1 Symbiotix Biotherapies Details
        2.19.2 Symbiotix Biotherapies Major Business
        2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions
        2.19.4 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 Symbiotix Biotherapies Recent Developments and Future Plans
    2.20 Osel
        2.20.1 Osel Details
        2.20.2 Osel Major Business
        2.20.3 Osel Microbiome Therapeutics Product and Solutions
        2.20.4 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 Osel Recent Developments and Future Plans
    2.21 Metabogen
        2.21.1 Metabogen Details
        2.21.2 Metabogen Major Business
        2.21.3 Metabogen Microbiome Therapeutics Product and Solutions
        2.21.4 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 Metabogen Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Microbiome Therapeutics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Microbiome Therapeutics Players Market Share
        3.2.2 Top 10 Microbiome Therapeutics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Microbiome Therapeutics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Microbiome Therapeutics Revenue and Market Share by Type (2016-2021)
    4.2 Global Microbiome Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Microbiome Therapeutics Revenue Market Share by Application (2016-2021)
    5.2 Microbiome Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Microbiome Therapeutics Revenue by Type (2016-2026)
    6.2 North America Microbiome Therapeutics Revenue by Application (2016-2026)
    6.3 North America Microbiome Therapeutics Market Size by Country
        6.3.1 North America Microbiome Therapeutics Revenue by Country (2016-2026)
        6.3.2 United States Microbiome Therapeutics Market Size and Forecast (2016-2026)
        6.3.3 Canada Microbiome Therapeutics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Microbiome Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Microbiome Therapeutics Revenue by Type (2016-2026)
    7.2 Europe Microbiome Therapeutics Revenue by Application (2016-2026)
    7.3 Europe Microbiome Therapeutics Market Size by Country
        7.3.1 Europe Microbiome Therapeutics Revenue by Country (2016-2026)
        7.3.2 Germany Microbiome Therapeutics Market Size and Forecast (2016-2026)
        7.3.3 France Microbiome Therapeutics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Microbiome Therapeutics Market Size and Forecast (2016-2026)
        7.3.5 Russia Microbiome Therapeutics Market Size and Forecast (2016-2026)
        7.3.6 Italy Microbiome Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Microbiome Therapeutics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Microbiome Therapeutics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Microbiome Therapeutics Revenue by Region (2016-2026)
        8.3.2 China Microbiome Therapeutics Market Size and Forecast (2016-2026)
        8.3.3 Japan Microbiome Therapeutics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Microbiome Therapeutics Market Size and Forecast (2016-2026)
        8.3.5 India Microbiome Therapeutics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Microbiome Therapeutics Market Size and Forecast (2016-2026)
        8.3.7 Australia Microbiome Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Microbiome Therapeutics Revenue by Type (2016-2026)
    9.2 South America Microbiome Therapeutics Revenue by Application (2016-2026)
    9.3 South America Microbiome Therapeutics Market Size by Country
        9.3.1 South America Microbiome Therapeutics Revenue by Country (2016-2026)
        9.3.2 Brazil Microbiome Therapeutics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Microbiome Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Microbiome Therapeutics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Microbiome Therapeutics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Microbiome Therapeutics Revenue by Country (2016-2026)
        10.3.2 Turkey Microbiome Therapeutics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Microbiome Therapeutics Market Size and Forecast (2016-2026)
        10.3.4 UAE Microbiome Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Related Reports
Global Electronic Health Records Market Research Report

The report on the Global Electronic Health Records Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Hyaluronic Acid Viscosupplementation Industry 2016 Market Research Report

The Global Hyaluronic Acid Viscosupplementation Industry 2016 Market Research Report is a professional and in-depth study on the current state of the  read more..


Global Health Care IT Market Size, Status and Forecast 2018-2025

The Global Health Care IT market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and  read more..


Global Wall Mount Fireplaces Market Insights, Forecast to 2025

Wall Mount Fireplaces Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Population Health Management Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Population Health Management Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Water Distiller Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Water Distiller Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Health Insurance Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Health Insurance Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Boat First Aid Kits Industry 2016 Market Research Report

The Global Boat First Aid Kits Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Boat First Aid Kits  read more..


Global Facial Aesthetics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Facial Aesthetics Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Vascular Graft Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Vascular Graft Market gives an estimation of the development of the market based on historical studies and also provides  read more..